Cryptogenic organizing pneumonia secondary prevention

Cryptogenic Organizing Pneumonia Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Cryptogenic organizing pneumonia from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic study of choice
History and Symptoms
Physical Examination
Laboratory Findings
Chest X Ray
Electrocardiogram
Ultrasonography/Echocardiography
CT
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Cryptogenic organizing pneumonia secondary prevention On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Cryptogenic organizing pneumonia secondary prevention All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Cryptogenic organizing pneumonia secondary prevention
CDC on Cryptogenic organizing pneumonia secondary prevention
Cryptogenic organizing pneumonia secondary prevention in the news
Blogs on Cryptogenic organizing pneumonia secondary prevention
Directions to Hospitals Treating Cryptogenic organizing pneumonitis
Risk calculators and risk factors for Cryptogenic organizing pneumonia secondary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Manpreet Kaur, MD [2]

Overview

Effective measures for the secondary prevention of cryptogenic organizing pneumonia include educating the patient about the need for early treatment to prevent long term disabling bronchiolitis obliterans and interstitial fibrosis.

Secondary Prevention

• Effective measures for the secondary prevention of cryptogenic organizing pneumonia include:
  • For occupational and environmental cryptogenic organizing pneumonia, patients should be informed about the causative agent and appropriate preventive measures.
  • For recurrent disease, the patient should be educated about the need for early treatment of cryptogenic organizing pneumonia which will prevents long-term disabling bronchiolitis obliterans and interstitial fibrosis.